// App-Quantinova.ai

: Clinical outcomes in Caucasian (C), African American (AA) and Asian men with metastatic castration-resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Susan Halabi

Principal Investigators

  • Sandipan Dutta

  • Kim N. Chi

  • Catherine M. Tangen

  • Daniel Peter Petrylak

  • John C. Araujo

  • Karim Fizazi

  • David I. Quinn

  • Celestia S. Higano

  • Ian Tannock

  • Eric Jay Small

  • William Kevin Kelly

Medical Centers

  • Duke University Medical Center, Durham, NC

  • Duke University, Durham, NC

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Yale Cancer Center, New Haven, CT

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

  • University of Washington and Fred Hutchinson Cancer Center, Seattle, WA

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • The Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA

Locations

  • United States

  • Canada

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • NCT00004001

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved